Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor. 2010

M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
Centro de Patogénese Molecular, Unidade dos Retrovirus e Infecções Associadas, Faculdade de Farmácia, Universidade de Lisboa, Portugal.

The human immunodeficiency virus replication cycle begins by sequential interactions between viral envelope glycoproteins with CD4 molecule and a member of the seven-transmembrane, G-protein-coupled, receptors' family (coreceptor). In this report we focused on the contribution of CCR8 as alternative coreceptor for HIV-1 and HIV-2 isolates. We found that this coreceptor was efficiently used not only by HIV-2 but particularly by HIV-1 isolates. We demonstrate that CXCR4 usage, either alone or together with CCR5 and/or CCR8, was more frequently observed in HIV-1 than in HIV-2 isolates. Directly related to this is the finding that the non-usage of CXCR4 is significantly more common in HIV-2 isolates; both features could be associated with the slower disease progression generally observed in HIV-2 infected patients. The ability of some viral isolates to use alternative coreceptors besides CCR5 and CXCR4 could further impact on the efficacy of entry inhibitor therapy and possibly also in HIV pathogenesis.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015728 Receptors, HIV Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120. AIDS Virus Receptors,HIV Receptors,HTLV-III Receptors,Receptors, AIDS Virus,Receptors, HTLV-III,HTLV III Receptors,Receptors, HTLV III,Virus Receptors, AIDS
D054401 Receptors, CCR8 CCR receptors with specificity for CHEMOKINE CCL1. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and MACROPHAGES. Antigens, CDw198,CC Chemokine Receptor 8,CCR8 Receptors,CDw198 Antigens

Related Publications

M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
November 1998, Journal of virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
September 2002, Clinical chemistry and laboratory medicine,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
March 1999, Journal of virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
August 2005, Journal of virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
February 1998, Biochemical and biophysical research communications,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
February 1998, Virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
December 2005, AIDS research and human retroviruses,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
June 2005, Virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
October 2009, Virology,
M Calado, and P Matoso, and Q Santos-Costa, and M Espirito-Santo, and J Machado, and L Rosado, and F Antunes, and K Mansinho, and M M Lopes, and F Maltez, and M O Santos-Ferreira, and J M Azevedo-Pereira
February 2018, AIDS research and human retroviruses,
Copied contents to your clipboard!